Danaher Corporation [NYSE: DHR] price plunged by -2.69 percent to reach at -$8.5. The company report on January 4, 2022 that Danaher To Present At J.P. Morgan Healthcare Conference.
Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 11:15 a.m. ET. The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
ABOUT DANAHERDanaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher’s globally diverse team of approximately 69,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life’s Potential. For more information, please visit www.danaher.com.
A sum of 4463056 shares traded at recent session while its average daily volume was at 2.48M shares. Danaher Corporation shares reached a high of $316.04 and dropped to a low of $305.365 until finishing in the latest session at $307.26.
The one-year DHR stock forecast points to a potential upside of 12.57. The average equity rating for DHR stock is currently 1.90, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Danaher Corporation [DHR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DHR shares is $351.42 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DHR stock is a recommendation set at 1.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cowen have made an estimate for Danaher Corporation shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on October 15, 2021. While these analysts kept the previous recommendation, BofA Securities raised their target price from $340 to $360. The new note on the price target was released on September 10, 2021, representing the official price target for Danaher Corporation stock. Previously, the target price had yet another raise to $306, while Credit Suisse analysts kept a Outperform rating on DHR stock. On July 23, 2021, analysts increased their price target for DHR shares from 280 to 320.
The Average True Range (ATR) for Danaher Corporation is set at 8.16, with the Price to Sales ratio for DHR stock in the period of the last 12 months amounting to 7.81. The Price to Book ratio for the last quarter was 5.47, with the Price to Cash per share for the same quarter was set at 3.58. Price to Free Cash Flow for DHR in the course of the last twelve months was 34.60 with Quick ratio for the last quarter at 1.10.
DHR Stock Performance Analysis:
Danaher Corporation [DHR] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.00. With this latest performance, DHR shares dropped by -1.82% in over the last four-week period, additionally plugging by 10.31% over the last 6 months – not to mention a rise of 34.31% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DHR stock in for the last two-week period is set at 41.14, with the RSI for the last a single of trading hit 35.01, and the three-weeks RSI is set at 44.47 for Danaher Corporation [DHR]. The present Moving Average for the last 50 days of trading for this stock 313.16, while it was recorded at 321.42 for the last single week of trading, and 287.38 for the last 200 days.
Insight into Danaher Corporation Fundamentals:
Danaher Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.10 and a Current Ratio set at 1.50.
DHR Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for DHR. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Danaher Corporation go to 22.30%.
Danaher Corporation [DHR] Insider Position Details
There are presently around $177,808 million, or 81.00% of DHR stock, in the hands of institutional investors. The top three institutional holders of DHR stocks are: VANGUARD GROUP INC with ownership of 49,736,739, which is approximately 0.744% of the company’s market cap and around 0.20% of the total institutional ownership; BLACKROCK INC., holding 45,621,495 shares of the stock with an approximate value of $14.41 billion in DHR stocks shares; and FMR LLC, currently with $9.3 billion in DHR stock with ownership of nearly 2.943% of the company’s market capitalization.
817 institutional holders increased their position in Danaher Corporation [NYSE:DHR] by around 26,233,740 shares. Additionally, 828 investors decreased positions by around 19,471,734 shares, while 299 investors held positions by with 517,404,384 shares. The mentioned changes placed institutional holdings at 563,109,858 shares, according to the latest SEC report filing. DHR stock had 161 new institutional investments in for a total of 7,231,831 shares, while 65 institutional investors sold positions of 2,236,111 shares during the same period.